Glaucoma Drainage Implant With Biodegradable Flow-Limiting Membrane
Solution Overview
Problem
Current glaucoma drainage implants face challenges such as hypotension due to excessive aqueous humor drainage and functional loss over time due to wear or adhesion, with existing valve mechanisms being complex and economically impractical or prone to failure.
Innovation Solution
A glaucoma drainage implant with a flow-limiting membrane made of biodegradable or biostable semi-permeable material, integrated with a fixing element and local drug delivery system, produced using electrospinning, which gradually decreases flow resistance with implantation time to prevent hypotension and fibrous tissue capsule formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If complex mechatronic valve mechanisms are used to prevent hypotension, then hypotension can be avoided, but device complexity and manufacturing cost increase significantly
Solution Approach 1:
The patent extracts the flow control function from complex mechanical valve mechanisms and transfers it to a simple porous membrane structure. The membrane is integrated directly into the drainage implant, eliminating the need for separate valve components while maintaining flow regulation capability through its inherent porosity properties.
Solution Approach 2:
The patent employs a porous membrane as the core flow-limiting component. The membrane's pore size and distribution are engineered to provide controlled resistance to aqueous humor flow, preventing hypotension without requiring complex mechanical structures. This approach leverages the natural flow-resistant properties of porous materials.
2Ease of operation
If mechanical valve mechanisms are used to regulate flow, then flow control is achieved, but manufacturing cost and device complexity increase
Solution Approach 1:
The patent adopts a disposable drainage implant design where the porous membrane is integrated into a single-use device. This eliminates the need for expensive, complex mechanical valves that would require precision manufacturing and assembly. The membrane-based solution is cheaper to manufacture and suitable for single implantation.
Solution Approach 2:
The patent replaces mechanical valve mechanisms with a passive porous membrane system. Instead of using moving parts, springs, or actuated components to control flow, the system relies on the inherent flow-resistant properties of the porous structure, eliminating mechanical complexity and reducing manufacturing costs.
3Productivity
If traditional drainage implants are used, then aqueous humor drainage is achieved, but functional loss occurs over time due to wear or adhesion
Solution Approach 1:
The patent incorporates a self-cleaning mechanism where the porous membrane structure resists clogging through its specific pore architecture. The membrane is designed to maintain its flow-regulating function over time by preventing adhesion and wear that would otherwise lead to functional loss. This self-maintaining property extends the operational duration of the implant.
4Productivity
If flow resistance is reduced to improve drainage, then aqueous humor outflow increases, but hypotension occurs due to excessive drainage
Solution Approach 1:
The patent controls the drainage rate by precisely engineering the parameters of the porous membrane, including pore size, porosity percentage, and membrane thickness. These parameters are optimized to provide appropriate flow resistance that maintains adequate drainage while preventing excessive outflow that would cause hypotension. The membrane acts as a passive flow regulator through its structural parameters.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The implant ensures consistent aqueous humor drainage, reducing intraocular pressure while avoiding hypotension and fibrosis, offering a cost-effective alternative to mechanical valve mechanisms with improved long-term functionality.
Implementation Method 1
a flow-limiting membrane (17, 20) is arranged in the inflow region of the implant for the purpose of limiting the flow of aqueous humor through the implant
Implementation Method 2
A glaucoma drainage implant with a flow-limiting membrane made of biodegradable or biostable semi-permeable material
Implementation Method 3
the membrane is made of biodegradable, semi-permeable material
Data Source
AI summary
The invention relates to an ocular implant for treating glaucoma. The problem addressed by the invention is to make it possible to drain aqueous humor from the anterior chamber of the eye into the subconjunctival or suprachoroidal space in order to lower the intraocular pressure in glaucoma cases. The device is to do away with the drawbacks of known valve mechanisms and should be economical to produce. In order to solve said problem, the glaucoma drainage implant is composed of an elongate, hollow main member in which a flow-limiting membrane is arranged in the inflow region.



